Cost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden.
Lars Lindholm(Umeå University), Kjell Asplund(Umeå University), Lars Weinehall(Umeå University), Måns Rosén
Cited by 46
Related Papers
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|1.6k
Clinical Practice Guidelines for the Management of Hypertension in the Community
|Journal of Clinical Hypertension|2013|1k